Martin Vogelbaum Net Worth & Insider Trades

Martin Vogelbaum - Director, Cara Therapeutics, Inc

As of September 16, 2022

What is Martin Vogelbaum's Net Worth?

The current estimated net worth of Cara Therapeutics, Inc's Director, Martin Vogelbaum, is estimated to be about $494.94K . Martin Vogelbaum owns about 44,988 units of Cara Therapeutics, Inc common stock. In the last 8 years at Cara Therapeutics, Inc, Martin Vogelbaum has sold an estimated value of $320.32K worth.

What is Martin Vogelbaum's Past Insider Trading?

Martin Vogelbaum's largest purchase order was 2,668,057 units , worth over $2.48M on February 5, 2014. Martin Vogelbaum's largest sale order was 8,640 units , worth over $112.75K on June 7, 2021. In total, Martin Vogelbaum has made about 13 transactions over 8 years of their time at Cara Therapeutics, Inc. Martin Vogelbaum usually trades in June, with the busiest year in 2022, 2016, 2020 and 2014. The most recent transaction was a sale order of 10,800 units , worth over $111.02K on September 16, 2022.

MARTIN VOGELBAUM

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Martin Vogelbaum's' Mailing Address?

  • Mailing address is 675 Almanor Ave Sunnyvale CA 94085 CA

What are Cara Therapeutics, Inc's Past Insider Trades?

Cara Therapeutics, Inc's most recent insider trade came on November 18, 2022 by Christopher Posner who sold 14,470 units worth $161.05K . In the last 8 years, insiders at Cara Therapeutics, Inc have sold an estimated value of $26.8M and bought an estimated value of $21.23M worth of shares. Insider trading is most common in June, with the busiest year in 2020. The most active traders at the company are Phd Frederique Menzaghi, Chief Scientific OffSVP-R&D,  Derek Chalmers, President & CEO,  and Jeffrey Ives, Director .

Cara Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1